Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa)

WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI: Ethical Principles for Medical Research Involving Human Subjects

Journal of obstetrics and gynaecology research · 2001 · 3.5K citations · Full text

Law, Health Policy, Clinical Research Regulation +13

World Medical Association Declaration of Helsinki

Not Available Not Available · JAMA · 2000 · 2.4K citations

Health Professions, Health Sciences, Clinical Medicine +2

Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation

BG Macik, PF Neuenschwander, PC Comp · Blood · 1993 · 505 citations · Full text

Medicine, Hematology, Physiology +10

Confidence Interval Criteria for Assessment of Dose Proportionality

Brian P. Smith · Pharmaceutical Research · 2000 · 352 citations

Pharmacy, Biostatistics, Dose-response Modeling +13

Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors

Barbara A. Konkle, Liselotte S. Ebbesen, Elisabeth Erhardtsen et al. · Journal of Thrombosis and Haemostasis · 2007 · 326 citations · Full text

Medicine, Hematology, Pharmacology +16